After years of hard work that included design, prototyping, anatomical experiments, biomechanical tests, and clinical studies, the CeLFI device has reached an advanced stage of development with promising success indicators, following the successful completion of the tenth operation at King Abdulaziz Medical City at the Ministry of National Guard Health Affairs.
These operations are performed using an innovative surgical stent (CeLFI), developed by a Saudi medical team from the Ministry of National Guard Health Affairs in cooperation with King Saud University, to treat diseases of the neck vertebrae associated with nerve suffocation caused by displacement of the vertebrae and pressure on the spinal cord, which may lead to gradual weakness of the limbs or loss of mobility.
This technique is characterized by the possibility of performing treatment through one surgery instead of two operations as previously followed, which contributes to reducing surgical intervention and potential complications, and contributes to accelerating the patient's recovery and improving the quality of healthcare provided.
The research team has been granted a patent by the U.S. Patent Office (USPTO) and licensed by the Saudi Food and Drug Authority (SFDA) for clinical use, making it the first locally innovative medical device to receive this license.
The medical team consists of:
- Dr. Sami Al Eissa - Consultant Spine Surgeon, King Abdulaziz Medical City at the Ministry of National Guard Health Affairs.
- Dr. Amro Fayez Al Habib – Consultant Spine Surgeon, King Saud University Medical City.
- Dr. Ayman Hassan Al Jazaeri – Consultant Pediatric Surgeon, King Saud University Medical City.
This achievement embodies the spirit of cooperation and integration between two of the most prestigious medical and scientific institutions in the Kingdom, in support of the process of health innovation, and the empowerment of research and development, and to reach global leadership.